i

Our Guides For CJC-1295 (no DAC)/Ipamorelin Combo?

We aim to simplify peptide research by offering:

  • ✓
    Straightforward instructions
  • ✓
    Clear reconstitution steps
  • ✓
    Regular updates

All protocols reference peer-reviewed data where possible and follow research standards.

Our Guides For CJC-1295 (no DAC)/Ipamorelin Combo?
📚

Snap-8 Dosing & Reconstitution Guide

Educational guide for reconstitution and dosing protocol

Standard / Gradual Approach (Reconstituted with 3 mL = 4 mg/mL)

PHASE DAILY DOSE APPROX. UNITS (PER INJECTION)
Weeks 1-4 400 mcg (0.4 mg) 10 units
Weeks 5-8 800 mcg (0.8 mg) 20 units
Weeks 9-12 1,200 mcg (1.2 mg) 30 units

Reconstitute the vial with 3 mL of bacteriostatic water to create a 4 mg/mL solution. If the calculated injection volume falls below 10 units, consider using a smaller insulin syringe for improved dosing accuracy.

  1. Draw 3.0 mL of bacteriostatic water into a sterile syringe.
  2. Inject the water slowly along the vial wall to minimize foam formation.
  3. Gently swirl the vial until the powder is completely dissolved (avoid vigorous shaking).
  4. Store the reconstituted solution at 2-8°C (refrigerator), protected from light.

Note: This guide is for research purposes only. Always consult with a qualified professional before use.

🔬

Protocol Overview

Enter your block description here. This text will appear below the title and above the bullet points.
  • Goal: Investigate metabolic support, fat oxidation, and regenerative properties
  • Schedule: Daily subcutaneous injections over a 12-week cycle
  • Dose Range: Start at 400 mcg daily, increasing to 1.2 mg daily
  • Reconstitution: Reconstitute with 3 mL to achieve a 4 mg/mL solution
  • Storage: Freeze lyophilized vials; refrigerate reconstituted solution at 2-8°C
🔬

Protocol Overview

The AOD-9604 6mg + CJC-1295 3mg + Ipamorelin 3mg (12mg Blend Vial) protocol combines a lipolytic peptide fragment with two growth hormone secretagogues to potentially enhance metabolic regulation and tissue repair. This research-focused regimen uses daily subcutaneous injections with gradual dose escalation over a 12-week cycle.
  • Goal: Investigate metabolic support, fat oxidation, and regenerative properties
  • Schedule: Daily subcutaneous injections over a 12-week cycle
  • Dose Range: Start at 400 mcg daily, increasing to 1.2 mg daily
  • Reconstitution: Reconstitute with 3 mL to achieve a 4 mg/mL solution
  • Storage: Freeze lyophilized vials; refrigerate reconstituted solution at 2-8°C
💉

Dosing Protocol

This protocol involves a single daily injection with gradual titration:
  • Daily Dose: Begin with 400 mcg (10 units) and increase to 1,200 mcg (30 units) as tolerated
  • Injection Frequency: Once daily, preferably at the same time each day
  • Cycle Length: 12 weeks (adjustable based on research parameters)
  • Note: Ensure consistent dosing intervals and accurate measurement using a 100-unit insulin syringe